She is taking on the pharmaceutical and for-profit medical industries by championing legislation to lower the cost of healthcare and prescription drugs.
Champion legislation to lower the cost of healthcare and prescription drugs.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
“As Congresswoman, Delia is a champion for getting health care costs down... She is taking on the pharmaceutical and for-profit medical industries by championing legislation to lower the cost of healthcare and prescription drugs.”
legacy_unverified · Source version not recorded · locator unknown
HB 3596 lists Delia C. Ramirez as a House co-sponsor and became Public Act 102-0490. The bill required electronic prescribing for controlled substances, part of reducing misuse and improving prescription oversight.
legacy_unverified · Source version not recorded · locator unknown
HB 3630 regulates pharmacy benefit managers and says a PBM may not require a patient to pay more than the lesser of cost-sharing or cash price, and may not restrict access to cheaper alternatives.
legacy_unverified · Source version not recorded · locator unknown
Her member record shows HB3630, INS-PHARMACY BENEFIT MANAGERS, and HB3493, DHFS-COVERAGE-NONCITIZENS, among her sponsored bills, along with HB3596 where she was added as co-sponsor.
legacy_unverified · Source version not recorded · locator unknown
The report notes Democratic work on lowering prescription drug costs and cites H.R. 4895, the Lowering Drug Costs for American Families Act, which would extend IRA drug price negotiation savings to private coverage.
legacy_unverified · Source version not recorded · locator unknown
Congress.gov lists H.R.3069 as the Medicare for All Act, status Introduced, with Rep. Delia C. Ramirez as an original cosponsor on 2025-04-29. The official summary says the bill would cover prescription drugs, prohibit cost-sharing and other charges for covered services, and require HHS to negotiate prescription-drug prices.
legacy_unverified · Source version not recorded · locator unknown
The 2026 Congressional Record Index entry for Rep. Ramirez lists, under bills and resolutions cosponsored, a Medicare measure to ensure appropriate payments under Medicare Advantage: H.R.9544, recorded at H4371 on 2026-07-02.
Assessments
Ramirez promised to champion, not necessarily enact, legislation lowering health-care and prescription-drug costs. In federal office she took concrete legislative action aligned with that promise, including original cosponsorship of the Medicare for All Act in the 119th Congress, whose provisions include prescription-drug coverage, no cost-sharing for covered services, and drug-price negotiation. Additional same-term health-cost-related cosponsorship reinforces that she materially advanced legislation in the promised area. Because the evidence shows legislative championing but not final enactment of broad cost reductions, this is delivered for the specific 'champion legislation' promise, with an effort badge reflecting serious action rather than completed policy enactment.
The promise was framed as championing legislation to lower healthcare and prescription-drug costs, not guaranteeing full cost reductions. The evidence shows Ramirez supported and sponsored relevant health coverage and prescription-drug affordability legislation, including pharmacy benefit manager regulation and prescription-related measures, which aligns with the legislative-championing portion of the pledge. However, the record provided does not establish that she delivered broad federal healthcare or prescription-drug cost reductions as a final enacted outcome during her congressional term, and some evidence predates her federal office. This supports a partial fulfillment with clear effort rather than full delivery.